Olli Carpén is professor of pathology at the University of Helsinki and scientific director at Helsinki Biobank. He is vice chair of the Assembly of Members of BBMRI-ERIC. His research focus is ovarian cancer and he is a PI in two EU-Horizon2020 funded projects (www.project-hercules.eu; www.deciderproject.eu)